Oculis Holding AG (OCS) Pension (2021 - 2026)
Oculis Holding AG's (OCS) quarterly Pension came in at $2.1 million in Q1 2026, up 46.4% year-on-year from $1.4 million in Q1 2025, and up 26.15% quarter-over-quarter from $1.7 million in Q4 2025.
Oculis Holding AG (OCS) Pension (2021 - 2026) Analysis & Trends
Oculis Holding AG's Pension history runs 6 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- On a quarterly basis, Pension rose 46.4% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 46.4% increase from a year earlier, with the FY2025 full-year figure at $1.6 million, down 24.25% from the prior year.
- Pension grew to $2.1 million in Q1 2026 per OCS's latest filing, from $1.7 million in the prior quarter.
- Across five years, Pension topped out at $2.1 million in Q4 2024 and bottomed at $94460.0 in Q4 2022.
- The 5-year median for Pension is $1.4 million (2025), against an average of $1.3 million.
- Across the five-year window, Pension slumped 89.69% in 2022 and jumped 768.85% in 2023, its largest moves.
- Year by year, Pension stood at $94460.0 in 2022, then soared by 768.85% to $820714.1 in 2023, then soared by 160.1% to $2.1 million in 2024, then decreased by 21.75% to $1.7 million in 2025, then grew by 26.15% to $2.1 million in 2026.
- Per Business Quant, the three latest OCS Pension figures stand at $2.1 million (Q1 2026), $1.7 million (Q4 2025), and $1.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.11 Mn |
| Dec 31, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 2.00 Mn |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 845,513.55 |
| Dec 31, 2023 | 820,714.06 |
| Sep 30, 2023 | 345,306.53 |
| Jun 30, 2023 | 339,213.54 |
| Dec 31, 2022 | 94,459.99 |
| Dec 31, 2021 | 916,404.27 |